
Bright Path Labs: Agile, scalable pharmaceutical manufacturing tech provider, addressing drug shortages and future health challenges.
Bright Path Laboratories (BPL) is dedicated to revolutionizing pharmaceutical manufacturing with its agile and patented technology. The company focuses on rapid, low-cost, and scalable domestic production of active pharmaceutical ingredients (APIs), addressing critical gaps in the drug supply chain. BPL's mission is to ensure a sustainable and reliable supply of essential medicines, particularly in response to crises like the COVID-19 pandemic and future health challenges.
BPL has made significant strides in the pharmaceutical industry by leveraging its advanced manufacturing capabilities to produce APIs efficiently. This innovation not only reduces dependency on foreign suppliers but also mitigates the risks associated with supply chain disruptions. The company's impact is evident in its ability to provide timely solutions to drug shortages, thereby enhancing the resilience of the American healthcare system.

Continuity Pharma

Brighton Biotech

Phlow
phlow-usa.com

Resilience
resilience.com

BiotechInnova
biotechinnova.com

Multiply Labs
multiplylabs.com

Ambiopharm
ambiopharm.com

August Bioservices
augustbio.com

Apertus Pharmaceuticals

US Specialty Formulations

ApiJect Systems
apiject.com

CuePath Innovation
cuepath.io

PathDrugomics

PleoPharma
pleopharma.com

American Injectables
americaninj.com
Companies similar to Bright Path Laboratories include Continuity Pharma, Brighton Biotech, Phlow and Resilience.
Bright Path Laboratories was founded in 2019.
Bright Path Laboratories' headquarters is located in Kannapolis, NC, US.
Bright Path Laboratories' most recent funding round was for $8.5M (USD) in November 2021.
As of Nov 18, 2021, Bright Path Laboratories has raised a total of $8.5M (USD).
Bright Path Laboratories has 23 employees as of Feb 5, 2024.